Robert P. Roche Jr., Director at ANTARES PHARMA, INC. (ATRS), bought 5,000 shares at $1.94 ($10K) on 2015-08-13, disclosed to the SEC on 2015-08-17.
Open-market purchase of $10k ATRS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ATRS | BUY | 2014-08-14 | $10K | — | Filing → |
| PATH | BUY | 2011-09-19 | $27K | — | Filing → |
| CEPH | SELL | 2008-12-23 | $1.8M | — | Filing → |